MUTAGENICITY 

Bacterial mutation test (Ames test) 

IQB-9320.HCl at concentrations ranging up to 5.000  mg/plate was added to plates of bacterial histidine dependent auxotrophic mutants of Salmonella typhimurium (strains  TA 1535, TA 1537, TA 98 and TA 100) and of a tryptophan dependent mutant of Escherichia coli (strain CM891). 

Two independent mutation tests were performed in the presence and absence of liver preparations from Aroclor 1254-induced rats (S9 mix). The first was a standard plate incorporation assay, the second involved a pre-incubation stage. 

No evidence of mutagenic activity was seen at any dose level of IQB-9302.HCl in either mutation test. The concurrent positive controls demonstrated the sensitivity of the assay and the metabolising activity of the liver preparation 
 

GLPs: This study was carried out according to the Good Laboratory Practice regulations published by OCDE, UK Good Laboratory Practice Regulations and the EC Council Directive 87,  at Huntingdon Life Sciences, Huntingdon, UK.   
Study Director Department of Genetic Toxicology:  Jonathan Kitching, B.Sc.  
QAU  Huntingdon: Margaret Blows 
QAU IQB: A. Soria, Biochemist 
Full Report: LIS 001/992164 
 
Conclusion:  In the preliminary mutagenicity tests on bacteria, IQB-9302 with and without hepatic microsomal activation was found to be inactive  
   
A complete set of mutagenicity tests have been planned to further evaluate mutagenic potential of IQB-9302 in compliance with Regulatory Guidelines. These are: 
  • The mouse micronucleus test >
  • The human lymphocyte test
 

 PROJECT HOMEPAGE